$RCUS 3 SEC Filings

Filed On	Filing
11 Feb 2025	Form 3: Markus Richard, Chief Medical Officer Holds 0 shares of Common Stock
10 Feb 2025	Form 3: Berger Dietmar, Director Holds 0 shares of Common Stock
07 Feb 2024	Form 3: Mercier Johanna, Director Holds 0 shares of Common Stock
10 Mar 2023	Form 3: Azoy Alexander, Chief Accounting Officer Holds 690 shares of Common Stock
08 Aug 2022	Form 3: Nuyten Dimitry Sa, Chief Medical Officer Holds 0 shares of Common Stock
13 Aug 2021	Form 3: Higgins Linda Slanec, Director Holds 0 shares of Common Stock
05 Aug 2021	Form 3: Lambert Nicole, Director Holds 0 shares of Common Stock
06 Jan 2021	Form 3: Quigley Michael, Director Holds 0 shares of Common Stock
18 Dec 2020	Form 3: Tang Carolyn C., General Counsel Holds 7,348 shares of Common Stock
18 Dec 2020	Form 3: Perlman Andrew J, Director Holds 2,525 shares of Common Stock
04 Aug 2020	Form 3: Goeltz Ii Robert C., Chief Financial Officer Holds 0 shares of Common Stock
17 Jul 2020	Form 3: Gilead Sciences Inc, 10% owner Holds 8,163,029 shares of Common Stock
13 Jul 2020	Form 3: Parsey Merdad, Director Holds 0 shares of Common Stock
26 May 2020	Form 3: Lacey David L., Director Holds 35,352 shares of Common Stock
12 Dec 2019	Form 3: Machado Patrick, Director No securities owned
30 Oct 2019	Form 3: Ribas Antoni, Director Holds 5,050 shares of Common Stock
04 Oct 2019	Form 3: Barker Jason, See Remarks
01 May 2019	Form 3: Grossman William, Chief Medical Officer No securities owned
25 Mar 2019	Form 3: Hemrajani Rekha, See Remarks Holds 25,252 shares of Common Stock
22 Oct 2018	Form 3: Hege Kristen, Director

Comments